Methods of antifibrinolytics administration and their side effects [12]

Neurosurgery

Volumn 58, Issue 5, 2006, Pages

  Sorimachi, Takatoshi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ACUTE HEART INFARCTION; ANGINA PECTORIS; BLOOD PRESSURE REGULATION; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; DEEP VEIN THROMBOSIS; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HUMAN; HYPOTENSION; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LETTER; MYOPATHY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 33646854555     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200605000-00045     Document Type: Letter

References (20)

1. Biswas CK, Milligan DA, Agte SD, Kenward DH, Tilley PB: Acute renal failure and myopathy after treatment with aminocaproic acid. Br Med J 281:115-116, 1980.
2. Britt CW, Light RR, Peters BH: Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Arch Neurol 37:187-188, 1980.
3. Charytan C, Purtilo D: Clomerular capillary thrombosis and acute renal failure after epsilon-aminocaproic acid therarpy. N Engl J Med 280:1102-1104, 1969.
4. Davies D, Howell DA: Tranexamic acid and arterial thrombosis. Lancet 1:49, 1977.
5. Fodstad H, Liliequist B: Spontaneous thrombosis of ruptured intracranial aneurysms during treatment with tranexamic acid (AMCA). Report of three cases. Acta Neurochir 49:129-144, 1979.
6. Gralnick HR, Greipp P: Thrombosis with epsilon aminocaproic acid therapy. Am J Clin Pathol 56:151-154, 1971.
7. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE: Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 97:771-778, 2002.
8. Kennard C, Henson RA: Myopathy due to epsilon aminocaproic acid. Muscle Nerve 3:202-206, 1980.
9. Mackay AR, Hoi Sang U, Weinstein PR: Myopathy associated with epsilon-aminocaproic acid therapy: Report of two cases. J Neurosurg 49:597-601, 1978.
10. Mayer SA: Rapid hemostatic therapy for intracerebral hemorrhage. Stroke 34:224-229, 2003.
11. Roos Y, Rinkel G, Vermeulen M, Algra A, van Gijn J: Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage. A major update of a Cochrane review. Stroke 34:2308-2309, 2003.
12. Roos Y, the Star Study Group: Antifibrinolytic treatment in subarachnoid hemorrhage. A randomized placebo-controlled trial. Neurology 54:77-82, 2000.
13. Roos Y, Vermeulen M, Rinkel GJ, Algra A, van Gijn J, Algra A: Systematic review of antifibrinolytics treatment in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 65:942-943, 1998.
14. Rydin E, Lundberg PO: Tranexamic acid and intracranial thrombosis. Lancet 2:49, 1976.
15. Sacco RL, Mayer SA: Epidemiology of intracerebral hemorrhage, in Feldmann E (ed): Intracerebral Hemorrhage. Armonk, Futura Publishing Co, 1994, pp 3-23.
16. Sano M, Hakusui H, Kojima C, Akimoto T: Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers [in Japanese]. Clin Pharmacol Ther 7:375-382, 1976.
17. Sorimachi T, Fujii Y, Morita K, Tanaka R: Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery 57:837-844, 2005.
18. Stroobandt G, Lambert O, Menard E: The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms. Acta Neurochir (Wien) 140:148-160, 1998.
19. Vanneste JA, van Wijingaarden GK: Epsilon-aminocarproic acid myopathy: Report of a case and literature review. Eur Neurol 21 242-248, 1982.
20. Vermeulen M, Lindsay KW, Murray GD, Cheah F, Muizelaar JP, Schannong M, Teasdale GM, van Greavel H, van Gijn J: Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311:432-437, 1984.